VT-122 [clinicaltrials_resource:568e6accb18ccac9ef8d3cee674ee62e]
intervention [clinicaltrials_vocabulary:intervention]
VT-122 [clinicaltrials_resource:568e6accb18ccac9ef8d3cee674ee62e]
Bio2RDF identifier
568e6accb18ccac9ef8d3cee674ee62e
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:568e6accb18ccac9ef8d3cee674ee62e
arm group [clinicaltrials_vocabulary:arm-group]
intervention desc [clinicaltrials_vocabulary:intervention-desc]
The following will be used in ...... and etodolac 340 mg capsules.
intervention name [clinicaltrials_vocabulary:intervention-name]
other name [clinicaltrials_vocabulary:other-name]
propranolol
identifier
clinicaltrials_resource:568e6accb18ccac9ef8d3cee674ee62e
title
VT-122
@en
type
label
VT-122 [clinicaltrials_resource:568e6accb18ccac9ef8d3cee674ee62e]
@en